Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
The aberrant up-regulation of the oncogenic transcription factor Forkhead box M1 (FoxM1) is associated with tumor development, progression and metastasis in a myriad of carcinomas, thus establishing it as an attractive target for anticancer drug development. FoxM1 overexpression in hepatocellular ca...
Guardado en:
Autores principales: | Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, Hina Bharti, Alo Nag |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6df4df68090a48b0a19f323347364a4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
por: Want MY, et al.
Publicado: (2017) -
Characterization of the miRNA regulators of the human ovulatory cascade
por: G. M. Yerushalmi, et al.
Publicado: (2018) -
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
por: Flavia Fondevila, et al.
Publicado: (2021) -
FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni G, et al.
Publicado: (2014) -
Investigation of the Effects of Artemisinin on Testis and Kidney Injury Induced by Doxorubicin
por: Tutun Hidayet, et al.
Publicado: (2019)